GROWTHSCondom Lie
Proper wording: Offers by Beta sales/marketing persons in words,
literature, brochures, book or web pages, are reference only, at
user's risk. Beta is not responsible for what others say offer or do.
Proper Beta terms: ~ZAP~/Apply not Treat; Application not Dose; Disrupt,Inhibit,
recover,relieve,restore,revive not Heal/Cure; Dormant not Dead; Recur not Destroy;
Subdue not Kill; Curtail not Eliminate; Product not Device/Unit; Outbreak,
Acquire,Contract not Infect; Virus not Germ; Afflicted,Infested not Diseased;
Skincare,therapeutic,cutaneous,healthaid,cosmetic,epidermal,remedy not Medical.
Proper claims: Beta uses Inhibit, Curtail & Alleviate.
Customers use Prevent blisters, Eliminate lesions, & Stop pain.
Contractors: Sales/marketing persons are independent, paid all
balances & responsible for expenses, income & personal taxes.
Inventor: Chester A. HEATH funded, developed, produced
& marketed first & only portable Viral Inhibitor. Resume.
Viral Inhibitor patents: Chester A. HEATH has US Domestic,
International PCT & 35 Foreign patent apply, non assigned.
Does Not heal: The Viral Inhibitor electro ~ZAPs~, disrupts & inhibits activities
of recurring Herpes family viruses, promoting natural healing without viral interference.
Safe: Viral Inhibitors have no side effects & shut off before discomfort, within safe levels.
Herpes research resumed: After discussions with an associate,
suffering cold sores since youth and former Biomedical Engineer,
HEATH had interest. He pinpointed flaws in past approaches & set
specifications. Herpes enter nerves after attacks & are inhibited.
HEATH researched skin properties & defined Beta electro signals
waveform. Circuit came at 2am! As HEATH breadboarded, a
cold sore formed. Applied, it disappeared fast! Resume.
Old science, new technology: In 1923 electro signals on disease had little success. In
1973 clinical studies showed promise on herpes. Since 1993 companies fail to produce.
By 2003 Chester A. HEATH patent, produce & market first & only portable Viral Inhibitor.
"False" claims: Hocus-pocus snake-oil claim Electro signals cure & heal.
However, a few work: electro stimulated nerve regeneration, pain relief
by TENS unit, & disruption of herpes activities by Beta Viral Inhibitor.
"Magic:" Frequency & resonance are analog waves. Nerve is digital pulses.
"Proteins, peptides, barriers": are common in all viruses. False "hocus
pocus" websites claim signals destroy, but Signals NOT work on HIV-AIDS.
"Unsafe" patents: Unproduced competing bogus patents 5133352,
5607461, 6083250 & 6594527, listed as prior art in Heath patent, have
dangerous currents of 1,9,18,27,30 to 100mA. Humans Sense 0.01mA,
to Discomfort 0.1mA, to Harm 1mA, and Pain to FATAL 10mA to 100mA,
see BOOK Ref. Beta produced first, portable, effective & safe product.
"Plagiarizing" lawsuit: Federal 2:04CV00288TS suit ended Jan06. Defense
sold HEATH's "Viral Inhibitor" as "ColdSoreEliminator" plagiarizing patent
5133352 wording & lost. Non party HEATH said "leave me alone", product
non-infringes & testified. Contempt/Judgement on Heath dismissed Apr08!
"New" litigation: Attempts to intimidate HEATH brought new lawsuits, State
intentional tortuous interfere & Federal retaliate infringe patents 5133352
+ patent 6083250 thrown out Jun07. Will show past non-infringe
of invalid competing unsafe bogus expired patent 5133352!
"Secret Prototype#3": Reverse engineered by plagiarizing "defendants" &
claimed “eliminator" "inventor". "Depotter" gave up Prototype#3 & insider
"micro" processor. "Defendants" & "inventor" took "micro" to developer
who applied for and assigned patent 7584001 to HEATH! "Inventor" went
to a producer to apply for another “micro” patent. Anticipate legal action.
Enclosed not sealed, don't expose Viral Inhibitor to liquids. Prevent contagious viral transfer. Cleaning, alcohol or sterilizing may not eliminate viruses from surfaces. Don't share, each needs their own personal Viral Inhibitor!
Manufacturer warrants Viral Inhibitor applies less than 10 volts across and less than 10 milliamps between probes and makes no claims for efficacy in use, nor supports views expressed on websites nor in other promotions. 20May10 11am